226 related articles for article (PubMed ID: 20967756)
21. MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?
Kałużna EM
Rev Med Virol; 2014 May; 24(3):169-85. PubMed ID: 24591085
[TBL] [Abstract][Full Text] [Related]
22. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
[TBL] [Abstract][Full Text] [Related]
23. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
24. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
25. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
26. Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.
Sejima H; Mori K; Ariumi Y; Ikeda M; Kato N
Virus Res; 2012 Jul; 167(1):74-85. PubMed ID: 22579597
[TBL] [Abstract][Full Text] [Related]
27. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
Ng IO; Liang ZD; Cao L; Lee TK
Cancer Res; 2000 Dec; 60(23):6581-4. PubMed ID: 11118037
[TBL] [Abstract][Full Text] [Related]
28. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells.
Zhou X; Thorgeirsson SS; Popescu NC
Oncogene; 2004 Feb; 23(6):1308-13. PubMed ID: 14647417
[TBL] [Abstract][Full Text] [Related]
29. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
Li Y; Yamane D; Lemon SM
J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.
Mukherjee A; Shrivastava S; Bhanja Chowdhury J; Ray R; Ray RB
J Virol; 2014 Jul; 88(14):7929-40. PubMed ID: 24789793
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5' Untranslated Region.
Thibault PA; Huys A; Amador-Cañizares Y; Gailius JE; Pinel DE; Wilson JA
J Virol; 2015 Jun; 89(12):6294-311. PubMed ID: 25855736
[TBL] [Abstract][Full Text] [Related]
33. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels.
Shibata C; Ohno M; Otsuka M; Kishikawa T; Goto K; Muroyama R; Kato N; Yoshikawa T; Takata A; Koike K
Virology; 2014 Aug; 462-463():42-8. PubMed ID: 25092460
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis.
Singaravelu R; Chen R; Lyn RK; Jones DM; O'Hara S; Rouleau Y; Cheng J; Srinivasan P; Nasheri N; Russell RS; Tyrrell DL; Pezacki JP
Hepatology; 2014 Jan; 59(1):98-108. PubMed ID: 23897856
[TBL] [Abstract][Full Text] [Related]
35. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
[TBL] [Abstract][Full Text] [Related]
36. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus.
Roelandt P; Obeid S; Paeshuyse J; Vanhove J; Van Lommel A; Nahmias Y; Nevens F; Neyts J; Verfaillie CM
J Hepatol; 2012 Aug; 57(2):246-51. PubMed ID: 22521345
[TBL] [Abstract][Full Text] [Related]
37. Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA.
Peng ZG; Fan B; Du NN; Wang YP; Gao LM; Li YH; Li YH; Liu F; You XF; Han YX; Zhao ZY; Cen S; Li JR; Song DQ; Jiang JD
Hepatology; 2010 Sep; 52(3):845-53. PubMed ID: 20593456
[TBL] [Abstract][Full Text] [Related]
38. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.
Yuan BZ; Zhou X; Durkin ME; Zimonjic DB; Gumundsdottir K; Eyfjord JE; Thorgeirsson SS; Popescu NC
Oncogene; 2003 Jan; 22(3):445-50. PubMed ID: 12545165
[TBL] [Abstract][Full Text] [Related]
39. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
Kim TY; Lee JW; Kim HP; Jong HS; Kim TY; Jung M; Bang YJ
Biochem Biophys Res Commun; 2007 Mar; 355(1):72-7. PubMed ID: 17292327
[TBL] [Abstract][Full Text] [Related]
40. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
